|
ZNF14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05470077116365E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.92169654925578E-11 |
| Normal-vs-Stage2 |
4.03639999202454E-09 |
| Normal-vs-Stage3 |
2.76123568454523E-12 |
| Normal-vs-Stage4 |
1.61426427780498E-13 |
| Stage1-vs-Stage2 |
8.800800E-01 |
| Stage1-vs-Stage3 |
3.108200E-02 |
| Stage1-vs-Stage4 |
5.183100E-03 |
| Stage2-vs-Stage3 |
1.251380E-01 |
| Stage2-vs-Stage4 |
2.528500E-02 |
| Stage3-vs-Stage4 |
3.039000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.01738667174823E-12 |
| Normal-vs-AfricanAmerican |
4.50289999953668E-07 |
| Normal-vs-Asian |
4.74759997981522E-09 |
| Caucasian-vs-AfricanAmerican |
7.920600E-01 |
| Caucasian-vs-Asian |
1.596790E-01 |
| AfricanAmerican-vs-Asian |
2.516800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.51829684777749E-11 |
| Normal-vs-Female |
9.17632636543431E-12 |
| Male-vs-Female |
5.407600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64850355588442E-11 |
| Normal-vs-Age(41-60Yrs) |
2.78329581604453E-11 |
| Normal-vs-Age(61-80Yrs) |
1.5202950010007E-11 |
| Normal-vs-Age(81-100Yrs) |
4.628600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.367600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.200000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.522000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.057000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.418400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.794200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.55658999999586E-05 |
| Classical-VS-Follicular |
9.600600E-01 |
| Classical-VS-Other |
6.141000E-01 |
| Classical-VS-Normal |
1.68560054802924E-10 |
| Tall-VS-Follicular |
1.205670E-04 |
| Tall-VS-Other |
3.934200E-01 |
| Tall-VS-Normal |
6.10622663543836E-15 |
| Follicular-VS-Other |
6.382600E-01 |
| Follicular-VS-Normal |
6.38879948944293E-10 |
| Other-VS-Normal |
2.695400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36800024033812E-10 |
| Normal-vs-N1 |
1.69952940609619E-12 |
| N0-vs-N1 |
2.140700E-03 |
|
|
